2 January 2025
Investment Evolution Credit
plc
("IEC",
the "Company" or the Group)
Subscription, Director/PDMR
Dealings, Related Party Transaction, Issue of Equity
and
Directorate
Changes
Investment Evolution Credit plc
(AQSE: IEC) - 2 January 2025: IEC, a global fintech group
specialising in online consumer loans, is pleased to announce that
it has raised £27,000 through the issue of 2,700,000 new ordinary
shares of £0.005 each in the Company ("Subscription Shares") at an
issue price of £0.01 each per share through a subscription by three
(3) Directors and one (1) PDMR of the Company
("Subscription").
Subscription
The Subscription is on the same
terms of the subscription and broker
option announced by the Company on 31
October 2024. The funds will be used to
fund the Company's business plan and for general working capital
purposes.
The participation in the
Subscription by Neil Patrick, a director of the Company, is a
related party transaction pursuant to Rule 4.6 of the AQSE Growth
Market Access Rulebook (the "Transaction"). The Directors of IEC
independent of the Transaction, being Glendys Aguilera and Paul
Mathieson, confirm that, having exercised reasonable care, skill
and diligence, the related party transaction is fair and reasonable
insofar as the shareholders of IEC are concerned.
Following the Subscription, Neil
Patrick, Marc Howells and Richard Leaver and the PDMR who
participated in the Subscription will hold the following number of
shares in the Company:
Name
|
Role
|
Number of shares held prior
to the Subscription
|
Number of Subscription Shares
subscribed for
|
Resultant shareholding
following the Subscription
|
Percentage shareholding in
enlarged issued share capital following
Subscription
|
Neil Patrick
|
Non-Executive Chairman
(Director)
|
Nil
|
300,000
|
300,000
|
0.46%
|
Marc Howells
|
CEO and Executive Director
|
Nil
|
900,000
|
900,000
|
1.39%
|
Robert Mennie
|
CFO (PDMR)
|
Nil
|
500,000
|
500,000
|
0.77%
|
Richard Leaver
|
Non-Executive Director
|
Nil
|
1,000,000
|
1,000,000
|
1.54%
|
Admission
Application has been made for the
2,700,000 Subscription Shares to be admitted to trading on AQSE
("Admission") and it is expected that Admission will take place on,
or around, 10 January 2025. The Subscription Shares will
rank pari
passu in all respects with the existing ordinary shares
of the Company.
Total Voting Rights
Following admission of the
Subscription Shares, the Company's enlarged issued share capital
will comprise 64,963,671 ordinary shares. The Company does not hold
any shares in treasury. The figure of 64,963,671 ordinary shares
may be used by shareholders in the Company as the denominator for
the calculations by which they will determine if they are required
to notify their interest in, or a change in their interest in, the
share capital of the Company under the Financial Conduct
Authority's Disclosure and Transparency Rules.
Directorate Changes
The Company is pleased to announce
that, further to the announcement on 17 December 2024, Mr. Marc
Howells and Dr. Richard Leaver have been appointed to the Board of
the Company as CEO and Independent Non-executive Director,
respectively, as of 1 January 2025. Biographic details and
disclosures in relation to Marc Howells and Richard Leaver pursuant
to AQSE Rule 4.9 are set out further below. In addition to his role
as Independent Non-Executive Director, Dr. Richard Leaver has also
been appointed as a member of the Audit & Risk, Remuneration
and Nomination & AQSE Rules Committees. Paul Mathieson has
retired from the Board of the Company effective 31 December
2024.
Marc Richard Howells
Mr. Marc Richard Howells currently
serves as a non-Board Chief Executive Officer of IEC from September
2024 and Director at Myogenes Limited since 2023. Previously
he was Chief Executive Officer at Goodbody Health Group from 2021
to 2022 and Advancis Limited (trading as Buddy Loans) from 2021 to
2022. Prior to this he was the Managing Director at Everyday Loans
from 2017 to 2019; George Banco from 2013 to 2019; First Banco from
2012 to 2013 and MBA International from 2010 to 2012. He was Chief
Executive Officer at Home Credit from 2007 to 2009. Mr. Howells
commenced his career at HFC Bank in 1984, moving to Citi Group in
2002, followed by Barclaycard in 2007.
Save as set out below, there is no
further information to disclose regarding Mr. Howells pursuant to
Rule 4.9 of the AQSE Growth Market Access Rulebook.
Mr. Marc Richard Howells (aged 59)
has held the following current and former directorships /
partnerships in the past five years:
Current Directorships / Partnerships
|
Former Directorships / Partnerships in the past five
years
|
|
Myogenes Limited
|
Advancis Holdings Limited
|
|
Advancis Limited
|
|
Blood Matters Ltd
|
|
Goodbody Botanicals Ltd
|
|
Goodbody Finance Ltd
|
|
Goodbody Health Limited
|
|
Goodbody Wellness Limited
|
|
Phytovista Laboratories
Ltd
|
|
Sativa Group Limited
|
|
|
In January 2021 Mr. Howells was
appointed as a director of Advancis Limited, having been approached
by the company in order to provide advice to the company in
relation to ongoing operational concerns and assist the company
with its forthcoming FCA review. In September 2021, following
examination of the company's financial positioning, Mr. Howells
advised the board of the company to appoint administrators, which
were appointed on 7 September 2021, and subsequently resigned
shortly after in October 2021. Mr. Howells was removed from the
company's Companies House in April 2022. The company was dissolved
following liquidation in December 2023 and there was an unsecured
creditor shortfall of approximately £26.5 million.
Mr. Howells holds 900,000 shares in
the Company following his participation in the Subscription on 31
December 2024, representing 1.39 per cent of the Company's enlarged
issued share capital. He does not hold any options or warrants over
new ordinary shares, in the Company.
Dr. Richard Alexander Leaver
Dr. Leaver is the founder and
Director of Greybrook Limited, his consultancy firm since 1998.
With a career spanning several industries, he has held roles such
as Non-executive Director (latterly as Deputy Chairman) at Image
Scan Holdings PLC (2014-2023) and CEO at Blue Star Capital PLC
(2008-2012). Earlier in his career, he worked at BAE Systems
(1983-1994) and Sagentia, after earning a BSc in Applied Physics
& Electronics, a PhD in Artificial Intelligence, and an MBA
from Durham University (the latter two degrees whilst employed by
BAE Systems). He is currently a regional director at Boardroom
Advisors, a mentor at Cambridge Judge Business School, and a
visiting professor at Hainan University, having previously served
as a guest professor at the University of Science and Technology
Beijing and a Dealmaker for the UK Government. His diverse
leadership experience includes partnerships, board positions, and
advisory roles across technology, finance, and academia.
Save as set out below, there is no
further information to disclose regarding Dr. Leaver pursuant to
Rule 4.9 of the AQSE Growth Market Access Rulebook.
Dr. Richard Alexander Leaver (aged
64) has held the following current and former directorships /
partnerships in the past five years:
Current Directorships / Partnerships
|
Former Directorships / Partnerships in the past five
years
|
|
Greybrook Limited
|
Boundary Capital Partners
LLP
|
|
Image Scan Holdings PLC
|
|
Metadventures Limited
|
|
Precision Sports Technologies
Ltd
Enigma Digital Limited
|
In June 2008, Dr. Leaver was
appointed a director of Pedagog Limited, an early-stage technology
company designing a cellular SIM based security camera. The
business was capital intensive and following, constrained market
conditions between 2009 to 2011, was unable to raise sufficient
working capital in order to continue operating. Consequently in
June 2011, the company entered into Creditors Voluntary Liquidation
proceedings. Dr. Leaver resigned as a director of the company in
February 2011 and was not involved in the CVL process before the
company was dissolved following liquidation in September 2013.
Unsecured creditor claims amounted to approximately £500,000 -
there was no repayment due to insufficient realisations
during the liquidation process.
Dr. Leaver was appointed as a
director of Enigma Digital Limited in April 2014. Enigma Digital
was a start up tech company focused on the retrieval of selective
business critical data and mobile phone data restoration. Over the
COVID-19 period the market for the services of Enigma Digital was
heavily impacted and did not revert to pre-pandemic levels. The
company was unable to secure sufficient financing and subsequently
in October 2021 the directors arranged for the company to undergo a
Creditors Voluntary Liquidation. The CVL completed on 21 December
2024 and the estimated total due to be returned to creditors is
approximately £60,000-90,000.
Dr. Leaver holds 1,000,000 shares in
the Company following his participation in the Subscription on 31
December 2024, representing 1.54 per cent of the Company's enlarged
issued share capital. He does not hold any options or warrants over
new ordinary shares, in the Company.
About IEC
IEC is an AI driven, consumer
finance fintech innovator with a mission to rehabilitate borrowers
through better technology and fairer products. IEC is an
experienced regulated licensed lender under the consumer brand Mr.
Amazing Loans in the United States with state consumer lending
licenses/certificates of authority in the 6 states of California,
Florida, Georgia, Illinois, Nevada and New Jersey and an
established track-record of regulatory compliance for over 14
years. IEC plans to expand its United States lending model to the
United Kingdom market in 2025 by providing £2,000 to £10,000 online
personal loans with fixed affordable repayments,
subject to the successful acquisition of an
existing UK FCA licensed consumer lender.
This announcement contains inside information for the purposes
of the UK Market Abuse Regulation and the Directors of the Company
accept responsibility for the contents of this
announcement.
Enquiries:
Investment Evolution Credit plc
|
|
Marc Howells
CEO
|
iec@investmentevolution.com
|
|
|
Cairn Financial Advisers LLP (IEC AQSE Corporate
Adviser)
|
|
Ludovico Lazzaretti
|
+44 (0) 20 7213
0880
|
Jo Turner
|
|
|
|
Axis Capital Markets Limited
(IEC Corporate Broker)
|
|
Lewis Jones
|
+44 (0) 20 3026 0449
|
|
|
For
more information please visit: www.investmentevolution.com/investors
Caution Regarding Forward Looking Statements
Certain statements made in this
announcement are forward-looking statements. These forward-looking
statements are not historical facts but rather are based on the
Company's current expectations, estimates, and projections about
its industry; its beliefs; and assumptions. Words such as
'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,'
'estimates,' and similar expressions are intended to identify
forward-looking statements. These statements are not a guarantee of
future performance and are subject to known and unknown risks,
uncertainties, and other factors, some of which are beyond the
Company's control, are difficult to predict, and could cause actual
results to differ materially from those expressed or forecasted in
the forward-looking statements. The Company cautions security
holders and prospective security holders not to place undue
reliance on these forward-looking statements, which reflect the
view of the Company only as of the date of this announcement. The
forward-looking statements made in this announcement relate only to
events as of the date on which the statements are made. The Company
will not undertake any obligation to release publicly any revisions
or updates to these forward-looking statements to reflect events,
circumstances, or unanticipated events occurring after the date of
this announcement except as required by law or by any appropriate
regulatory authority.
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a.
|
Name
|
Richard Leaver
|
2
|
Reason for notification
|
|
a.
|
Position/Status
|
Director
|
b.
|
Initial notification/
Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a.
|
Name
|
Investment Evolution Credit
plc
|
b.
|
LEI
|
984500ARA55ED7411Y77
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary Shares
ISIN: GB00BPQC9525
|
b.
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
|
|
Price(s) per share (p)
|
Volume(s)
|
|
1p
|
1,000,000
|
|
|
d.
|
Aggregated information
- Volume
- Price
|
- 1,000,000
- 1 pence per share
|
e.
|
Date of the transaction
|
31 December 2024
|
f.
|
Place of the transaction
|
AQSE, London
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a.
|
Name
|
Neil Patrick
|
2
|
Reason for notification
|
|
a.
|
Position/Status
|
Director
|
b.
|
Initial notification/
Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a.
|
Name
|
Investment Evolution Credit
plc
|
b.
|
LEI
|
984500ARA55ED7411Y77
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary Shares
ISIN: GB00BPQC9525
|
b.
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
|
|
Price(s) per share (p)
|
Volume(s)
|
|
1p
|
300,000
|
|
|
d.
|
Aggregated information
- Volume
- Price
|
- 300,000
- 1 pence per share
|
e.
|
Date of the transaction
|
31 December 2024
|
f.
|
Place of the transaction
|
AQSE, London
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a.
|
Name
|
Robert Mennie
|
2
|
Reason for notification
|
|
a.
|
Position/Status
|
PDMR
|
b.
|
Initial notification/
Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a.
|
Name
|
Investment Evolution Credit
plc
|
b.
|
LEI
|
984500ARA55ED7411Y77
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary Shares
ISIN: GB00BPQC9525
|
b.
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
|
|
Price(s) per share (p)
|
Volume(s)
|
|
1p
|
500,000
|
|
|
d.
|
Aggregated information
- Volume
- Price
|
- 500,000
- 1 pence per share
|
e.
|
Date of the transaction
|
31 December 2024
|
f.
|
Place of the transaction
|
AQSE, London
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a.
|
Name
|
Marc Howells
|
2
|
Reason for notification
|
|
a.
|
Position/Status
|
Director
|
b.
|
Initial notification/
Amendment
|
Initial Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a.
|
Name
|
Investment Evolution Credit
plc
|
b.
|
LEI
|
984500ARA55ED7411Y77
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary Shares
ISIN: GB00BPQC9525
|
b.
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
|
|
Price(s) per share (p)
|
Volume(s)
|
|
1p
|
900,000
|
|
|
d.
|
Aggregated information
- Volume
- Price
|
- 900,000
- 1 pence per share
|
e.
|
Date of the transaction
|
31 December 2024
|
f.
|
Place of the transaction
|
AQSE, London
|